The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe

Mori, Hideki; Schol, Jolien; Geeraerts, Annelies; Huang, I-Hsuan; Jandee, Sawangpong; Gonlachanvit, Sutep; Tseng, Ping-Huei; Lu, Ching-Liang; Kamiya, Takeshi; Kim, Nayoung; Lee, Yeong Yeh; Kuribayashi, Shiko; Tack, Jan; Suzuki, Hidekazu

doi:10.3390/jcm9103189

Submit to this Journal Review for this Journal Edit a Special Issue

Article Menu

...

Open AccessArticle

The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe

¹,

¹,

^1,2,

³,

⁴

⁵,

⁶,

⁷,

⁸

⁹

¹ and

^10,*

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Diseases (TARGID), University of Leuven, 3000 Leuven, Belgium

Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Hatyai 90110, Thailand

Center of Excellence on Neurogastroenterology and Motility, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

⁴

Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan

⁵

Endoscopy Center for Diagnosis and Treatment, Taipei Veterans General Hospital, Taipei 112, Taiwan

⁶

Department of Medical Innovation, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan

⁷

Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea

⁸

School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 15200, Malaysia

⁹

Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan

¹⁰

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara 259-1193, Japan

Author to whom correspondence should be addressed.

J. Clin. Med. 2020, 9(10), 3189; https://doi.org/10.3390/jcm9103189

Received: 21 August 2020 / Revised: 19 September 2020 / Accepted: 29 September 2020 / Published: 1 October 2020

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)

View Full-Text Download PDF

Browse Figures

Review Reports Citation Export

Abstract

Background: The new coronavirus disease (COVID-19) has high infection and mortality rates, and has become a pandemic. The infection and mortality rates are lower in Asian countries than in European countries. This study aimed to conduct a survey on the effects of COVID-19 on the capacity to perform gastrointestinal motility tests in Asian countries compared with European countries. Methods: We used the questionnaire previously established by our team for researchers in European countries. The correlation between the decreased rate of gastrointestinal motility and function tests, and the infection/mortality rates of COVID-19 and stringency of a government’s interventions in each country was analysed and protective measures were assessed. Results: In total, 58 gastroenterologists/motility experts in Asian countries responded to this survey. The infection/mortality rates of COVID-19 and Stringency Index had a significant impact on the testing capacity of oesophageal manometry and catheter-based pH monitoring. In European countries, most facilities used filtering facepiece 2/3 (FFP2/3) masks during oesophageal motility studies. Meanwhile, in Asian countries, most facilities used surgical masks. Conclusion: The total infection and mortality rates of COVID-19 can affect the rate of gastrointestinal motility testing and the type of protective equipment that must be used. View Full-Text

Keywords: SARS-CoV-2; COVID-19; oesophageal manometry; catheter-based pH-monitoring; wireless pH-monitoring (Bravo^®); anorectal manometry; breath tests; motility disorders of the gastrointestinal tract; infection prevention

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

Supplementary File 1:
PDF-Document (PDF, 71 KiB)

Share and Cite

MDPI and ACS Style

Mori, H.; Schol, J.; Geeraerts, A.; Huang, I.-H.; Jandee, S.; Gonlachanvit, S.; Tseng, P.-H.; Lu, C.-L.; Kamiya, T.; Kim, N.; Lee, Y.Y.; Kuribayashi, S.; Tack, J.; Suzuki, H. The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe. J. Clin. Med. 2020, 9, 3189. https://doi.org/10.3390/jcm9103189

AMA Style

Mori H, Schol J, Geeraerts A, Huang I-H, Jandee S, Gonlachanvit S, Tseng P-H, Lu C-L, Kamiya T, Kim N, Lee YY, Kuribayashi S, Tack J, Suzuki H. The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe. Journal of Clinical Medicine. 2020; 9(10):3189. https://doi.org/10.3390/jcm9103189

Chicago/Turabian Style

Mori, Hideki, Jolien Schol, Annelies Geeraerts, I-Hsuan Huang, Sawangpong Jandee, Sutep Gonlachanvit, Ping-Huei Tseng, Ching-Liang Lu, Takeshi Kamiya, Nayoung Kim, Yeong Y. Lee, Shiko Kuribayashi, Jan Tack, and Hidekazu Suzuki. 2020. "The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe" Journal of Clinical Medicine 9, no. 10: 3189. https://doi.org/10.3390/jcm9103189

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe

Abstract

Supplementary Material

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI